New patent for MIRUM drug LIVMARLI

March 4, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for LIVMARLI Livmarli is a drug marketed by Mirum and is included in one NDA. The generic ingredient in LIVMARLI is maralixibat chloride. Additional details are…

The post New patent for MIRUM drug LIVMARLI appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.